5.72
Schlusskurs vom Vortag:
$5.85
Offen:
$5.84
24-Stunden-Volumen:
25,678
Relative Volume:
0.35
Marktkapitalisierung:
$175.73M
Einnahmen:
$8.98M
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-4.2687
EPS:
-1.34
Netto-Cashflow:
$-24.83M
1W Leistung:
-12.00%
1M Leistung:
-17.46%
6M Leistung:
-29.90%
1J Leistung:
-31.99%
Profound Medical Corp Stock (PROF) Company Profile
Firmenname
Profound Medical Corp
Sektor
Branche
Telefon
647-476-1350
Adresse
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Vergleichen Sie PROF mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PROF
Profound Medical Corp
|
5.9091 | 175.73M | 8.98M | -31.39M | -24.83M | -1.34 |
![]()
ABT
Abbott Laboratories
|
131.70 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
100.76 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
375.31 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.69 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
72.11 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-23 | Eingeleitet | Lake Street | Buy |
2024-07-16 | Hochstufung | Stifel | Hold → Buy |
2023-11-28 | Eingeleitet | Stifel | Hold |
2023-08-04 | Herabstufung | Raymond James | Strong Buy → Outperform |
2023-03-21 | Herabstufung | Jefferies | Buy → Hold |
2020-09-15 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Profound Medical Corp Aktie (PROF) Neueste Nachrichten
(PROF) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
(PRN) Stock Evaluation Report (PRN:CA) - news.stocktradersdaily.com
Waterstone Impact Fund, Tim Tebow, Partner With eFuse - The Esports Advocate
Bronstein, Gewirtz & Grossman, LLC Is Investigating Profound Medical Corp. (PROF) And Encourages Investors to Connect - markets.businessinsider.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Methanex CorporationMEOH - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp.PROF - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Profound Medical Corp. (PROF) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com
Profound Medical stock hits 52-week low at $5.62 amid market challenges By Investing.com - Investing.com South Africa
Profound Medical stock hits 52-week low at $5.62 amid market challenges - Investing.com Australia
Wolf Haldenstein Adler Freeman & Herz LLP is investigating - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws - GlobeNewswire Inc.
Profound Medical to Host Investor Event at AUA 2025 - TipRanks
Save the Date: Profound Medical to Host Investor Event at AUA 2025 - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating Profound Medical Corp. (PROF) And Encourages Stockholders to Connect - ACCESS Newswire
iCAD, RamSoft to Deliver ProFound AI-Powered Mammography Solutions - Medical Product Outsourcing
Raymond James Financial Inc. Takes $7.46 Million Position in Piper Sandler Companies (NYSE:PIPR) - The AM Reporter
(PRN) Comprehensive Trading Strategy Report (PRN:CA) - Stock Traders Daily
PROF Investors Have Opportunity to Join Profound Medical Corp. Fraud Investigation with the Schall Law Firm - Business Wire
Chairman of the Board & CEO of Profound Medical Picks Up 2.6% More Stock - simplywall.st
Insider Spends US$144k Buying More Shares In Profound Medical - Yahoo Finance
Public market insider buying at Profound Medical (PRN) - The Globe and Mail
(PRN) Investment Performance Report (PRN:CA) - Stock Traders Daily
Profound Medical Corp. (NASDAQ:PROF) Sees Large Growth in Short Interest - Defense World
(PRN) Pivots Trading Plans and Risk Controls (PRN:CA) - Stock Traders Daily
Securities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - Business Wire
How To Trade (PROF) - Stock Traders Daily
(PRN) Dynamic Trading Report (PRN:CA) - Stock Traders Daily
Profound Medical revises financials, corrects revenue overstatement By Investing.com - Investing.com South Africa
Profound Medical Corp. (NASDAQ:PROF) Q4 2024 Earnings Call Transcript - Insider Monkey
Profound Medical revises financials, corrects revenue overstatement - Investing.com
Profound Medical Q4 2024 revenue jumps 108% to USD 4.2M - Medical Buyer
Stifel maintains Buy on Profound Medical, $12 target post-Q4 results - Investing.com Canada
Profound Medical Corp. (PROF) reports earnings - Quartz
Profound Medical Corp. SEC 10-K Report - TradingView
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: R - GuruFocus.com
Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: Record Revenue and Improved ... - Yahoo Finance
Profound Medical stock hits 52-week low at $6.61 amid market challenges - MSN
Profound Medical Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Profound Medical Q4 2024 beats EPS forecast By Investing.com - Investing.com UK
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings call transcript: Profound Medical Q4 2024 beats EPS forecast - Investing.com
Profound Medical Corp. Q4 Income Retreats, But Beats Estimates - Nasdaq
iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America - Yahoo Finance
What To Expect From Profound Medical Corp (TSX:PRN) Q4 2024 Earnings - GuruFocus.com
Truist Financial Corp Buys Shares of 50,000 Profound Medical Corp. (NASDAQ:PROF) - Defense World
Finanzdaten der Profound Medical Corp-Aktie (PROF)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):